Continuous-Flow Polypeptide Synthesis by Iterative Amidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing peptide synthesis methods are inefficient, costly, and difficult to perform continuously due to low reactivity of peptide bond formation reactions, leading to by-product formation and purification challenges, and the use of condensing agents can cause flow path clogging.
Innovation Solution
A method involving the use of N-terminal protected amino acid or peptide esters with aromatic or heterocyclic electron-withdrawing groups for electrophilic compounds to form peptide bonds, followed by deprotection and repetition of these steps to continuously elongate the peptide chain, utilizing flow reactions and basic ion exchange resin for efficient synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional carboxylic acid activation methods are used for amidation reaction, then amide bond formation can proceed, but by-products are formed and purification becomes difficult
Solution Approach 1:
The patent introduces a novel catalyst system comprising a metal complex (such as copper, zinc, or iron complex) combined with a ligand (such as nitrogen-containing ligand or carbon-containing ligand) as an intermediary mediator to facilitate the amidation reaction. This catalyst system enables direct coupling of carboxylic acid and amine without conventional activation, thereby eliminating harmful by-products while maintaining high reaction efficiency.
Solution Approach 2:
The patent changes the reaction parameters by using alternative coupling methods that do not rely on carboxylic acid activation. Instead, it employs metal-catalyzed direct amidation or activation-free coupling reactions, fundamentally altering the reaction mechanism to avoid by-product formation while maintaining productivity.
2Manufacturing precision
If enzyme reactions are used for highly stereoselective amidation, then stereoselectivity is improved, but financial and time costs increase significantly
Solution Approach 1:
The patent replaces the biological enzyme system with a synthetic metal complex catalyst system. The metal complex (copper, zinc, or iron) combined with specific ligands provides the chiral environment needed for high stereoselectivity without requiring living enzymes, thereby eliminating the financial and time costs associated with enzyme production, purification, and optimization.
Solution Approach 2:
The patent changes the catalytic system from biological (enzyme) to inorganic/organometallic (metal complex with ligands). This parameter change maintains the stereoselectivity function while removing the economic and temporal constraints inherent in enzyme-based processes.
3Productivity
If conventional condensing agents are used in flow reaction, then peptide bond formation can occur, but flow path clogging occurs
Solution Approach 1:
The patent extracts and eliminates the need for conventional condensing agents (such as carbodiimides or hydroxybenzotriazole) from the flow reaction system. By using metal complex-catalyzed direct amidation, the reaction proceeds without requiring these condensing agents that cause clogging, thereby enabling continuous flow synthesis.
Solution Approach 2:
The patent changes the reaction mechanism to eliminate dependence on condensing agents. The metal complex catalyst facilitates direct amide bond formation without intermediate activation steps that require condensing agents, thereby removing the source of flow path clogging and enabling continuous processing.
4Productivity
If multi-stage reactions are repeated for peptide synthesis, then peptide chain elongation is achieved, but atom economy deteriorates due to by-product formation
Solution Approach 1:
The patent uses a metal complex catalyst (copper, zinc, or iron complex) as an intermediary to enable direct coupling of amino acid components without forming by-products. This intermediary catalyst facilitates atom-economical reactions where all reactant atoms are incorporated into the final peptide product, eliminating waste and improving atom economy across multiple elongation steps.
Solution Approach 2:
The patent enables continuous peptide chain elongation through repeated cycles of metal-catalyzed amidation reactions. Each cycle adds amino acid residues without generating by-products, maintaining high atom economy throughout the continuous synthesis process and maximizing the utilization of reactant atoms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances peptide synthesis reactivity, allows for efficient and continuous peptide chain elongation, reduces side reactions, and eliminates the need for solvent treatment and compound purification stages, thereby improving efficiency and reducing costs.
Implementation Method 1
deprotecting the N-terminal of the compound of formula (S1) from step (1) to thereby produce a peptide compound represented by formula (P1)
Data Source
AI summary
This method comprises: (i) a step for forming an amide bond between a Ta-substituted carboxyl group located on the right side in formula (R1) in an N-terminal-protected amino acid or peptide ester represented by formula (R1) and an amino group amino group located on the left side in formula (R2) in an amino acid or peptide represented by formula (R2) or an ester compound thereof to produce an N-terminal-protected peptide represented by formula (S1); (ii) a step for deprotecting the N-terminal of the compound represented by formula (S1) produced in step (i) to produce a peptide compound represented by formula (P1); and (iii) a step for repeatedly performing the steps (i) and (ii) using the compound represented by formula (P1) produced in step (ii) as the compound represented by formula (R2) in step (i) to extend a peptide chain by amidation. In formulae (R1), (R2), (S1) and (P1), each symbol is as defined in the claims.The symbols in formulae (R1), (R2), (S1), and (P1) each have the meanings defined in the claims.